Hutchison China Meditech Ltd.
50 announcements.
50 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 10:00 | 03-12-2024 | HCM | Hutchison China Meditech Ltd | HUTCHMED and Innovent Announce ELUNATE Approval |
| 08:30 | 29-11-2024 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 09:30 | 20-11-2024 | HCM | Hutchison China Meditech Ltd | Appointment of Independent Non-executive Director |
| 08:30 | 31-10-2024 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 09:30 | 21-10-2024 | HCM | Hutchison China Meditech Ltd | Vesting of awards under the LTIP |
| 07:00 | 16-10-2024 | HCM | Hutchison China Meditech Ltd | SAVANNAH: clinically meaningful response rate |
| 08:00 | 24-09-2024 | HCM | Hutchison China Meditech Ltd | Japan Approval for FRUZAQLA |
| 09:30 | 30-08-2024 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 07:00 | 30-08-2024 | HCM | Hutchison China Meditech Ltd | Update on Fruquintinib for Gastric Cancer in China |
| 10:00 | 06-08-2024 | HCM | Hutchison China Meditech Ltd | LTIP and Share Option Scheme |
| 12:00 | 31-07-2024 | HCM | Hutchison China Meditech Ltd | 2024 Interim Results and Business Updates |
| 09:30 | 28-06-2024 | HCM | Hutchison China Meditech Ltd | Blocklisting Six Monthly Return |
| 09:30 | 28-06-2024 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 09:30 | 26-06-2024 | HCM | Hutchison China Meditech Ltd | HUTCHMED to Announce 2024 HY Financial Results |
| 07:00 | 24-06-2024 | HCM | Hutchison China Meditech Ltd | European Commission Approval for FRUZAQLA |
| 09:30 | 31-05-2024 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 15:00 | 17-05-2024 | HCM | Hutchison China Meditech Ltd | Retirement of Chairman and new Chairman appointed |
| 13:00 | 10-05-2024 | HCM | Hutchison China Meditech Ltd | Result of AGM |
| 09:30 | 08-05-2024 | HCM | Hutchison China Meditech Ltd | Directorate Change |
| 13:30 | 26-04-2024 | HCM | Hutchison China Meditech Ltd | Positive CHMP Opinion for Fruquintinib |
| 09:30 | 22-04-2024 | HCM | Hutchison China Meditech Ltd | Vesting of Awards Under the LTIP |
| 09:30 | 08-04-2024 | HCM | Hutchison China Meditech Ltd | 2023 Annual Report and Notice of AGM |
| 09:00 | 14-03-2024 | HCM | Hutchison China Meditech Ltd | LTIP and Share Option Scheme |
| 08:30 | 05-03-2024 | HCM | Hutchison China Meditech Ltd | Vesting of awards under the LTIP |
| 11:30 | 28-02-2024 | HCM | Hutchison China Meditech Ltd | 2023 Full Year Results and Business Updates |
| 08:30 | 01-02-2024 | HCM | Hutchison China Meditech Ltd | HUTCHMED to Announce 2023 Final Results |
| 08:30 | 29-12-2023 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 08:30 | 29-12-2023 | HCM | Hutchison China Meditech Ltd | Blocklisting Six Monthly Return |
| 10:00 | 21-12-2023 | HCM | Hutchison China Meditech Ltd | Overseas Regulatory Announcement |
| 10:04 | 07-12-2023 | HCM | Hutchison China Meditech Ltd | Overseas Regulatory Announcement |
| 08:30 | 30-11-2023 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 07:00 | 09-11-2023 | HCM | Hutchison China Meditech Ltd | U.S. FDA Approval of FRUZAQLAâ„¢ (fruquintinib) |
| 09:30 | 24-10-2023 | HCM | Hutchison China Meditech Ltd | Vesting of awards under the LTIP |
| 09:30 | 29-09-2023 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 09:30 | 14-09-2023 | HCM | Hutchison China Meditech Ltd | Director’s Share Dealing |
| 09:30 | 31-08-2023 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 07:00 | 21-08-2023 | HCM | Hutchison China Meditech Ltd | Sovleplenib Phase 3 Study Meets Primary Endpoint |
| 09:30 | 07-08-2023 | HCM | Hutchison China Meditech Ltd | Exercise of Share Options by a Director |
| 12:00 | 31-07-2023 | HCM | Hutchison China Meditech Ltd | Interim Results and Business Updates |
| 09:30 | 13-07-2023 | HCM | Hutchison China Meditech Ltd | Changes to Board and Technical Committee |
| 09:30 | 29-06-2023 | HCM | Hutchison China Meditech Ltd | Blocklisting Six Monthly Return |
| 09:30 | 26-06-2023 | HCM | Hutchison China Meditech Ltd | HUTCHMED to Announce 2023 Half-Year Results |
| 07:00 | 16-06-2023 | HCM | Hutchison China Meditech Ltd | Phase III FRESCO-2 Results in The Lancet |
| 15:39 | 15-06-2023 | HCM | Hutchison China Meditech Ltd | MAA of Fruquintinib Validated by the EMA |
| 10:00 | 06-06-2023 | HCM | Hutchison China Meditech Ltd | LTIP and Share Option Scheme |
| 09:30 | 31-05-2023 | HCM | Hutchison China Meditech Ltd | Total Voting Rights |
| 07:00 | 26-05-2023 | HCM | Hutchison China Meditech Ltd | Fruquintinib NDA Granted Priority Review by FDA |
| 13:15 | 12-05-2023 | HCM | Hutchison China Meditech Ltd | Annual General Meeting Poll Results |
| 09:30 | 12-05-2023 | HCM | Hutchison China Meditech Ltd | Board of Directors and Board Committee Membership |
| 09:30 | 10-05-2023 | HCM | Hutchison China Meditech Ltd | Appointment of Independent NED |